A Rollercoaster Plunge into 2022

Gregory Y. H. Lip; Anne Rigby; Christian Weber

doi:10.1055/s-0041-1741073

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2022; 122(01): 001-004
DOI: 10.1055/s-0041-1741073

Editorial

A Rollercoaster Plunge into 2022

Gregory Y. H. Lip

¹Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

²Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

,

Anne Rigby

³Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany

,

Christian Weber

³Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany

⁴German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany

⁵Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Lip GYH, Rigby A, Weber C. Looking Back on 2020, Looking Forward to 2021. Thromb Haemost 2021; 121 (01) 1-3
2 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2020 Editors' Choice Papers. Thromb Haemost 2021; 121 (01) 109-114
3 Weber CRA, Lip GYH. Thrombosis and Haemostasis 2021 Editors' Choice Papers. Thromb Haemost 2022; 123 (01) 163-170
4 Henning C, Branopolski A, Follert P. et al. Endothelial β1 integrin-mediated adaptation to myocardial ischemia. Thromb Haemost 2021; 121 (06) 741-754
5 Tian J, Adams MJ, Tay JWT. et al. Estradiol-responsive miR-365a-3p interacts with tissue factor 3'UTR to modulate tissue factor-initiated thrombin generation. Thromb Haemost 2021; 121 (11) 1483-1496
6 Vilar R, Lukowski SW, Garieri M, Di Sanza C, Neerman-Arbez M, Fish RJ. Chemical modulators of fibrinogen production and their impact on venous thrombosis. Thromb Haemost 2021; 121 (04) 433-448
7 Aliotta A, Bertaggia Calderara D, Zermatten MG, Alberio L. Sodium-calcium exchanger reverse mode sustains dichotomous ion fluxes required for procoagulant COAT platelet formation. Thromb Haemost 2021; 121 (03) 309-321
8 Yamashita A, Nishihira K, Gi T. et al. Pathological features of ruptured coronary plaque and thrombus interfaces: fibrin and von Willebrand factor as platelet scaffolds on rupture sites. Thromb Haemost 2021; 121 (02) 234-241
9 Billett HH, Reyes-Gil M, Szymanski J. et al. Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost 2020; 120 (12) 1691-1699
10 de Jong A, Dirven RJ, Boender J. et al. Ex vivo improvement of a von Willebrand disease type 2A phenotype using an allele-specific small-interfering RNA. Thromb Haemost 2020; 120 (11) 1569-1579
11 Hsu L-W, Chen P-W, Chang W-T, Lee WH, Liu PY. The role of ROCK in platelet-monocyte collaborative induction of thromboinflammation during acute coronary syndrome. Thromb Haemost 2020; 120 (10) 1417-1431
12 Fanikos J, Murwin D, Gruenenfelder F. et al. Global use of idarucizumab in clinical practice: outcomes of the RE-VECTO surveillance program. Thromb Haemost 2020; 120 (01) 27-35
13 Akhmedov A, Montecucco F, Costantino S. et al. Cardiomyocyte-specific JunD overexpression increases infarct size following ischemia/reperfusion cardiac injury by downregulating Sirt3. Thromb Haemost 2020; 120 (01) 168-180
14 Paterson GG, Young JM, Willson JA. et al. Hypoxia modulates platelet purinergic signalling pathways. Thromb Haemost 2020; 120 (02) 253-261
15 Izquierdo I, Barrachina MN, Hermida-Nogueira L. et al. A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade. Thromb Haemost 2020; 120 (02) 262-276
16 Chueh T-H, Cheng Y-H, Chen K-H, Chien CT. Thromboxane A2 synthase and thromboxane receptor deletion reduces ischaemia/reperfusion-evoked inflammation, apoptosis, autophagy and pyroptosis. Thromb Haemost 2020; 120 (02) 329-343
17 Tahir S, Wagner AH, Dietzel S. et al. Endothelial CD40 mediates microvascular von Willebrand factor-dependent platelet adhesion inducing inflammatory venothrombosis in ADAMTS13 knockout mice. Thromb Haemost 2020; 120 (03) 466-476
18 Wan LM, Zhang SK, Li SB. et al. Heparanase facilitates PMA-induced megakaryocytic differentiation in K562 cells via interleukin 6/STAT3 pathway. Thromb Haemost 2020; 120 (04) 647-657
19 Hearn JI, Green TN, Chopra M. et al. N-methyl-D-aspartate receptor hypofunction in Meg-01 cells reveals a role for intracellular calcium homeostasis in balancing megakaryocytic-erythroid differentiation. Thromb Haemost 2020; 120 (04) 671-686
20 Smadja DM, Chocron R, Rossi E. et al. Autoregulation of pulsatile bioprosthetic total artificial heart is involved in endothelial homeostasis preservation. Thromb Haemost 2020; 120 (09) 1313-1322
21 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19. Thromb Haemost 2020; 120 (12) 1629-1641
22 Schulman S, Hu Y, Konstantinides S. Venous thromboembolism in COVID-19. Thromb Haemost 2020; 120 (12) 1642-1653
23 Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in severe COVID-19: implications for acute care. Thromb Haemost 2020; 120 (12) 1654-1667
24 Polzin A, Dannenberg L, Thienel M. et al. Noncanonical effects of oral thrombin and factor Xa inhibitors in platelet activation and arterial thrombosis. Thromb Haemost 2021; 121 (02) 122-130
25 Huang J, Huang S, Ma Z. et al. Ibrutinib suppresses early megakaryopoiesis but enhances proplatelet formation. Thromb Haemost 2021; 121 (02) 192-205
26 Potpara TS, Lip GYH, Blomstrom-Lundqvist C. et al. The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost 2021; 121 (03) 270-278
27 Vayne C, Nguyen T-H, Rollin J. et al. Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia. Thromb Haemost 2021; 121 (03) 322-331
28 Garcia A, Dunoyer-Geindre S, Fish RJ, Neerman-Arbez M, Reny JL, Fontana P. Methods to investigate miRNA function: focus on platelet reactivity. Thromb Haemost 2021; 121 (04) 409-421
29 Locke M, Longstaff C. Extracellular histones inhibit fibrinolysis through noncovalent and covalent interactions with fibrin. Thromb Haemost 2021; 121 (04) 464-476
30 Basu MK, Massicano F, Yu L. et al. Exome sequencing identifies abnormalities in glycosylation and ANKRD36C in patients with immune-mediated thrombotic thrombocytopenic purpura. Thromb Haemost 2021; 121 (04) 506-517
31 Atiq F, van de Wouw J, Sorop O. et al. Endothelial dysfunction, atherosclerosis, and increase of von Willebrand factor and factor VIII: a randomized controlled trial in swine. Thromb Haemost 2021; 121 (05) 676-686
32 Schilling U, Dingemanse J, Dobrow M. et al. Insights from in vitro and clinical data to guide transition from the Novel P2Y12 antagonist selatogrel to clopidogrel, prasugrel, and ticagrelor. Thromb Haemost 2021; 121 (06) 755-766
33 Arroyo AB, Águila S, Fernández-Pérez MP. et al. miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?. Thromb Haemost 2021; 121 (09) 1138-1150
34 von Hundelshausen P, Lorenz R, Siess W, Weber C. Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thromb Haemost 2021; 121 (11) 1395-1399
35 Gissler MC, Scherrer P, Anto-Michel N. et al. Deficiency of endothelial CD40 induces a stable plaque phenotype and limits inflammatory cell recruitment to atherosclerotic lesions in mice. Thromb Haemost 2021; 121 (11) 1530-1540
36 Fabris E, Korjian S, Coller BS. et al. Pre-hospital antiplatelet therapy for STEMI patients undergoing primary percutaneous coronary intervention: what we know and what lies ahead. Thromb Haemost 2021; 121 (12) 1562-1573
37 Wan J, Konings J, de Laat B, Hackeng TM, Roest M. Added value of blood cells in thrombin generation testing. Thromb Haemost 2021; 121 (12) 1574-1587
38 Vaughan CJ, Cronin H, Ryan PM, Caplice NM. Obesity and COVID-19: a Virchow's triad for the 21st century. Thromb Haemost 2020; 120 (11) 1590-1593